Astrid Persson
1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
Persson, Astrid E. LU
; Kjellén, Elisabeth
LU
; Garmo, Hans
; Adrian, Gabriel
LU
; Stattin, Pär
; Widmark, Anders
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2026)
In Radiotherapy and Oncology
215.
- Contribution to journal › Article
-
Mark
Medication-defined scoring of urinary toxicity: an ongoing survey and agreement analysis on practices in ultra-hypofractionation trials in prostate cancer
Persson, Astrid E. LU
; Schmidt-Hegemann, Nina-Sophie
and Draulans, Cédric
(2026)
13th Øresund Workshop on Radiotherapy
- Contribution to conference › Poster
-
Mark
Ultrahypofraktionerad strålbehandling vid lokaliserad prostatacancer i klinisk vardag: en kohortbeskrivning från Skånes universitetssjukhus
Persson, Astrid E. LU
; Kjellén, Elisabeth
LU
; Ståhl, Olof
; Adrian, Gabriel
LU
; Scherman, Jonas
; Stattin, Pär
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2026)
Onkologidagarna 2026
- Contribution to conference › Poster
-
Mark
Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436
- Contribution to journal › Letter
- 2025
-
Mark
Prostate-specific antigen bounce after prostate ultra-hypofractionation: associations with 5-year outcomes in the phase 3 trial HYPO-RT-PC
Persson, Astrid E. LU
; Kjellén, Elisabeth
LU
; Thellenberg-Karlsson, Camilla
; Beckman, Lars
; Gunnlaugsson, Adalsteinn
LU
and Nilsson, Per
LU
(2025)
ESTRO 2025
In Radiotherapy and Oncology
206(Suppl 1).
p.1873-1874
- Contribution to journal › Published meeting abstract
-
Mark
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
Persson, Astrid E. LU
; Hallqvist, Andreas
; Bjørn Larsen, Louise
; Rasmussen, Mette
LU
; Scherman, Jonas
; Nilsson, Per
LU
; Tønnesen, Hanne
LU
and Gunnlaugsson, Adalsteinn
LU
(2025)
12th Øresund Workshop on Radiotherapy
- Contribution to conference › Abstract
-
Mark
Stereotactic Body Radiotherapy as Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - Beyond the Abstract
Persson, Astrid E. LU
(2025)
- Other contribution › Web publication
- 2024
-
Mark
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
Persson, Astrid E. LU
; Hallqvist, Andreas
; Bjørn Larsen, Louise
; Rasmussen, Mette
LU
; Scherman, Jonas
; Nilsson, Per
LU
; Tønnesen, Hanne
LU
and Gunnlaugsson, Adalsteinn
LU
(2024)
In Radiation Oncology
19.
- Contribution to journal › Article
-
Mark
Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
Persson, Astrid E LU
; Kjellén, Elisabeth
LU
; Garmo, Hans
; Adrian, Gabriel
LU
; Stattin, Pär
; Widmark, Anders
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2024)
ESTRO 2024
In Radiotherapy and Oncology
194(Suppl 1).
p.2287-2291
- Contribution to journal › Published meeting abstract
-
Mark
Morbiditet från urinvägar och tarm enligt registerdata efter ultrahypofraktionerad strålbehandling för lokaliserad prostatacancer vid 10 år i HYPO-RT-PC-studien
Persson, Astrid E LU
; Kjellén, Elisabeth
LU
; Garmo, Hans
; Adrian, Gabriel
LU
; Stattin, Pär
; Widmark, Anders
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2024)
Onkologidagarna 2024
- Contribution to conference › Poster